Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid TumorsAdnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Thoracic Neoplasms, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, bronchial neoplasm, bronchogenic carcinoma, cancer, endocrine system disorder, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, lung disorder, lung neoplasm, male reproductive organ cancer, male reproductive system disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, prostate cancer, prostate disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder, small cell lung carcinomaRecruitingPhase 12026-04-07NCT07424547

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Conjupro Biotherapeutics, Inc.3

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
BRCR GlobalPlantationUnited States12
Florida Clinical Trials GroupPlantationUnited States9
Next Oncology AustinAustinUnited States4
Next Oncology San AntonioSan AntonioUnited States6
NEXT Oncology VirginiaFairfaxUnited States40